About

Julien Lamps is Product Manager for Lonza’s Capsule and Health Ingredients business unit, focusing primarily on inhalation and HPMC portfolios. Mr Lamps graduated from Ecole Nationale Supérieure de Chimie de Lille with an engineering degree in chemistry in 2004. He later joined Capsugel as a Quality Assurance Engineer in the Colmar plant in 2011. In this role he worked at the interphase of operations and customers, specialising in co-ordinating new product introductions to develop innovative offers around modified release profiles.

Contributions

GI/ORAL

REMOVING CLINICAL TRIAL BIAS WITH OVER-ENCAPSULATION

Frédérique Bordes-Picard, Julien Lamps and Stephen Rode discuss the considerations to take into account when using over-encapsulation to blind clinical trials, including the advantages of hydroxypropyl methylcellulose over gelatin as a material.

More contributions

PULMONARY

AN ADVANCED CUSTOMISABLE COMPREHENSIVE DPI CAPSULE PORTFOLIO OFFERING

Frédérique Bordes-Picard and Julien Lamps discuss the factors driving development in the area of capsule-based dry powder inhalers, and how the company’s Capsugel^® Zephyr™ portfolio offering is perfectly positioned to meet and exceed industry’s growing and evolving requirements.

EXPERT VIEW

ADVANCED CAPSULE TECHNOLOGIES: DRY POWDER INHALERS TO TARGET DISEASE

Frédérique Bordes-Picard and Julien Lamps discuss the value of capsule-based dry powder inhalers in the modern respiratory market, the factors driving development in this area and considerations for matching a capsule to a device and formulation.